58 research outputs found
Utilization of Glycoprotein IIB/IIIA Receptor Antagonists in the Management of Acute Coronary Syndrome: Focus on Patient Characteristics and Formulary Decisions
No full textRetrospective, Observational Comparison of Eptifibatide vs Abciximab in Patients Undergoing Percutaneous Coronary Intervention
No full textReoPro rules: results from the ‘Do Tirofiban and ReoPro Give Similar Efficacy Trial’ (TARGET)
No full text
Learning from the Recently Completed Oral Glycoprotein IIb/IIIa Receptor Antagonist Trials
No full textThrombocytopenia complicating treatment with intravenous glycoprotein IIb/IIIa receptor inhibitors: A pooled analysis
No full textCost Efficacy of Platelet Glycoprotein IIb/IIIa Antagonists in Clinical Trials and Clinical Practice
No full textSynergistic effect of thrombus aspiration and abciximab in primary percutaneous coronary intervention
No full textEvaluation on the safety and efficacy of tirofiban in the treatment of acute coronary syndrome
No full textEfficacy and Safety of Tirofiban in High-Risk Patients With Non-ST-Segment Elevation Acute Coronary Syndromes
No full text- …
